May 14th, 2025
Description
The concomitant atrial fibrillation (AF)ablation and left atrial appendage occlusion (LAAO) device implantation has been recently approved in the US after the publication of the Option Trial. Presentations in this continuing medical education activity will evaluate post study approval real life experiences including safety and efficacy as well as appropriate management and follow up post concomitant AF ablation and LAAO implantation procedure.
For pricing information, see pricing tab below.
Streams
| Name | |
|---|---|
| You must be signed in to view streams. Click here to sign into your OSU CCME Account. |
Dates and Times
Start: 5/14/2025 6:30 PM
End: 5/14/2025 8:15 PM
Objectives
At the conclusion of this activity, learners will be able to:
1. Review clinical data for left atrial appendage occlusion device and pulse field ablation.
2. Identify patient criteria for left atrial appendage occlusion device and pulse field ablation.
3. Review implantation steps for left atrial appendage occlusion and pulse field ablation.
4. Describe the importance of pre-procedure cardiac CT in understanding anatomy, transseptal access and the size of left atrial appendage occlusion device.
5. Discuss the biophysics of pulse field ablation.
6. Identify procedural steps for pulse field ablation.
7. Review upcoming left atrial closure device and ongoing studies.
8. Discuss data of post left atrial closure device antithrombotic therapy.
Agenda
Pricing
| Tier | Price |
|---|---|
| Physician | $0.00 |
| Resident/Fellow | $0.00 |
| Advanced Practice Provider | $0.00 |
| Other | $0.00 |
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
, the faculty, the planners, the reviewers, and the CME provider have no relevant financial relationship with a commercial interest (defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients), that relates to the content that will be discussed in the educational activity.